Kairos Pharma, Ltd. (KAPA) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
0250K500K750K1M1M2M2M2MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EBITDA

EBITDA
-2M-2M-1M-1M-1000K-750K-500K-250K1Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income Variation
050100150200250300350400Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
088175262350438525612700Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Price-to-Earning Ratio

P/E Ratio
-7-6-5-4-3-2-101Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
075K150K225K300K375K450K525K600KQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
0875K2M3M4M4M5M6M7MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0750K2M2M3M4M4M5M6MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics